AbbVie Inc. (ABBV) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AbbVie Inc. (ABBV) CIK: 0001551152 --- Reporting Owner --- Name: FALK THOMAS J CIK: 0001222890 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock, $0.01 par value Date: 2026-05-08 | Code: A (Grant or award) Shares: +1,118 | Price: $0.00 Shares Owned After: 2,321 | Ownership: D (Direct) Footnotes: [F1] These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). --- Holdings --- [Holding #1] Security: Common Stock, $0.01 par value Ownership: I (Indirect) Footnotes: [F2] The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. --- Footnotes (Complete Index) --- F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F2: The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. --- Signature --- /s/ /s/ T.O. Odutayo, Attorney-in-Fact for Thomas J. Falk (2026-05-12)